January 31, 2015     Japanese 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
Yakult Honsha, OncoTherapy Science to Team up in R&D for New Antibody Drugs for Lung Cancer Treatments

Tokyo, Apr 28, 2004 (JCN) - Yakult Honsha has announced that it has agreed with OncoTherapy Science to collaborate in R&D in the field of antibody drugs for cancer treatments.

Under this alliance, the two companies will strive to develop new antibody drugs aimed at the treatment of lung cancer.

By Dale Hug Staff Writer

Copyright © 2015 JCN. All rights reserved. A division of Japan Corporate News Network KK.

ACN Newswire
CSR Report Download
Annual Reports

  More >>    
Most Popular

About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)